# AI Support Agent and Semaglutide Adherence at a Digital Clinic: 16,556 Patients

A retrospective Australian study compared six-month semaglutide adherence before and after an AI support agent launched.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/the-chatbot-and-the-adjusted-model
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# AI Support Agent and Semaglutide Adherence at a Digital Clinic: 16,556 Patients

Raw six-month adherence rose after an AI support agent launched, while the adjusted model linked that period with higher odds of attrition.

Editorial profile: [Neil Sanders](https://buythisglp.com/authors/neil-sanders)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20266 min readUpdated November 2026

Adherence before and after an AI launch · raw comparison · 47.3% → 53.2% · higher unadjusted adherence · adjusted model · OR 1.178 · higher adjusted attrition odds · Factors associated with attrition: · heavy month-1 tracking (OR 15.8) · pauses (2.5) · cost (2.5) · The study measured fulfilled medication orders.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

Research on [how long people stay on a GLP-1](https://buythisglp.com/research/how-long-do-people-stay-on-a-glp1) uses several measures of persistence. An Australian service examined fulfilled semaglutide orders before and after it launched an AI support agent [\[1\]](https://buythisglp.com/research/the-chatbot-and-the-adjusted-model#ref-1).

## Two comparisons from the same records

The study used records for 16,556 adults. Six-month adherence was 53.2% after launch and 47.3% before launch in the unadjusted comparison [\[1\]](https://buythisglp.com/research/the-chatbot-and-the-adjusted-model#ref-1).

The postlaunch period was associated with higher odds of attrition after adjustment for measured factors. The odds ratio was 1.178 (95% CI 1.052 to 1.318). A matched analysis also found higher odds of attrition after launch.

## What the study can tell us about support

A separate [study of digital engagement and persistence](https://buythisglp.com/research/semaglutide-persistence-digital-engagement) tracked patients in a French early-access program. Both studies examined patterns in engagement without assigning patients to use the digital tools.

The Australian study counted fulfilled orders as its adherence measure. Its comparison cannot isolate the effect of the support agent from other changes over time. Some authors were affiliated with Eucalyptus Health and Amigo AI.

## Frequently asked

Did the AI support agent improve adherence?

The unadjusted and adjusted comparisons differed. The study design cannot isolate what changed because of the agent.

## Sources

1.  \[1\] Talay L, Xu C, Alderete J, Hom J, Tan M, Ahuja N (2026). AI Patient Support and 6-Month Medication Adherence in a Digital Obesity Program: A Retrospective Analysis Diabetes, Obesity & Metabolism. [PMID 42575845](https://doi.org/10.1111/dom.71181)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
